PER 10.0% 11.0¢ percheron therapeutics limited

e-mail to management, page-20

  1. 12,668 Posts.
    lightbulb Created with Sketch. 3846
    The financing of the Phase 2 is the most important issue for us and had been stated on the 7 December 2011.

    As Phase 2 is the next big step and the company hasn't got the money to do it is important for the sh to know if things are progressing well or not. We don't need details, just the general reassurance. Otherwise people get nervous, me included. The best people and technology are worthless if they can't come up with results due to financing problems.

    That's why I think management must give us an update.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.